Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3). Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2025 Jun. 20];2(3). Available from: https://journals.pagepress.org/hmr/article/view/365